ClassID:

109211

C12N2310/52 - CPC Classification

Classification description:

Structure or type of the nucleic acid; Physical structure branched

Recent Application in this class:
#1
20260109982
2026-04-23

OLIGONUCLEOTIDES FOR MAPT MODULATION

#2
20260098265
2026-04-09

COMPOSITIONS AND METHODS FOR TREATMENT OF SPINOCEREBELLAR ATAXIAS

#3
20250346897
2025-11-13

COMPOSITIONS AND METHODS FOR TREATMENT OF MICROSATELLITE DNA EXPANSION DISORDERS

#4
20250332279
2025-10-30

PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING GLIOBLASTOMAS

#5
20250188471
2025-06-12

NONCOVALENTLY BRANCHED OLIGONUCLEOTIDE COMPOSITIONS

#6
20250043081
2025-02-06

OLIGONUCLEOTIDE DENDRIMERS FOR DYNAMIC AND FUNCTIONAL COLLOIDAL CRYSTAL ENGINEERING

#7
20240327836
2024-10-03

MODIFIED OLIGONUCLEOTIDES TARGETING SNPs

#8
20240293550
2024-09-05

BRANCHED OLIGONUCLEOTIDES

#9
20240287526
2024-08-29

COMPOSITIONS AND METHODS FOR DELIVERING THERAPEUTIC OLIGONUCLEOTIDES TO THE CENTRAL NERVOUS SYSTEM

#10
20240175032
2024-05-30

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF PCSK9

#11
20240132892
2024-04-25

OLIGONUCLEOTIDE-BASED MODULATION OF C9orf72

#12
20240132885
2024-04-25

MODULATION OF TRANSTHYRETIN EXPRESSION

#13
20240046114
2024-02-08

On-Chip Nanoscale Storage System Using Chimeric DNA

#14
20230151361
2023-05-18

PEPTIDE NUCLEIC ACID CONJUGATES

#15
20230132627
2023-05-04

Oligonucleotides and methods for preparing

#16
20230120244
2023-04-20

HYPERBRANCHED POLYMERS AND POLYPLEXES AND DNA OR RNA DELIVERY SYSTEMS INCLUDING THE SAME

#17
20230095192
2023-03-30

SYNTHETIC AGONISTS OF DNA-PK AND THEIR USE

#18
20230061751
2023-03-02

UNIVERSAL DYNAMIC PHARMACOKINETIC-MODIFYING ANCHORS

#19
20220251555
2022-08-11

O-methyl rich fully stabilized oligonucleotides

#20
20220251554
2022-08-11

OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA

#21
20220090069
2022-03-24

OLIGONUCLEOTIDES FOR HTT-1A MODULATION

#22
20220047728
2022-02-17

RNA nanoparticles and method of use thereof

#23
20210371863
2021-12-02

High efficiency aptamer complex comprising branched DNA and aptamer, and use thereof

#24
20210139873
2021-05-13

RNA silencing nanozymes

#25
20210115083
2021-04-22

RNA nanoparticles for brain tumor treatment

#26
20210103824
2021-04-08

On-chip nanoscale storage system using chimeric DNA

#27
20210095281
2021-04-01

Modulation of transthyretin expression

#28
20210085793
2021-03-25

Branched oligonucleotides

#29
20210071177
2021-03-11

Modified oligonucleotides targeting SNPs

#30
20200385737
2020-12-10

OLIGONUCLEOTIDE-BASED MODULATION OF C9orf72

#31
20200308584
2020-10-01

Oligonucleotide compounds for targeting huntingtin mRNA

#32
20200157533
2020-05-21

Meta-stable oligonucleotides junctions for delivery of therapeutics

#33
20200095577
2020-03-26

Peptide nucleic acid conjugates

#34
20200087663
2020-03-19

O-methyl rich fully stabilized oligonucleotides

#35
20190390200
2019-12-26

RNA-based compositions and adjuvants for prophylactic and therapeutic treatment

#36
20190247507
2019-08-15

Branched oligonucleotides

#37
20190225965
2019-07-25

Oligonucleotide compounds for targeting huntingtin mRNA

#38
20190169613
2019-06-06

MODULATION OF TRANSTHYRETIN EXPRESSION

#39
20190119682
2019-04-25

miRNA for treatment of breast cancer

#40
20190119672
2019-04-25

SMALL INTERFERENCE RNA COMPLEX WITH INCREASED INTRACELLULAR TRANSMISSION CAPACITY

#41
20190106452
2019-04-11

RNA nanoparticles for brain tumor treatment

#42
20190100775
2019-04-04

Engineered nucleic acid-targeting nucleic acids

#43
20190062743
2019-02-28

Multimeric oligonucleotide compounds

#44
20190055555
2019-02-21

Polynucleotide nanoparticles for the modulation of gene expression and uses thereof

#45
20190055551
2019-02-21

PRNA three-way junctions

#46
20190032050
2019-01-31

RNA nanoparticle for treatment of gastric cancer

#47
20180346908
2018-12-06

POLYNUCLEOTIDES FOR MULTIVALENT RNA INTERFERENCE, COMPOSITIONS AND METHODS OF USE THEREOF

#48
20180273946
2018-09-27

MODULATION OF TRANSTHYRETIN EXPRESSION

#49
20180094263
2018-04-05

Oligonucleotide compounds for targeting huntingtin mRNA

#50
20180092997
2018-04-05

RNA nanoparticles and method of use thereof

#51
20180080029
2018-03-22

Composition for preventing or treating atopic dermatitis comprising X-shape DNA structure as active ingredient

#52
20180030444
2018-02-01

Multimeric oligonucleotide compounds having non-nucleotide based cleavable linkers

#53
20180023085
2018-01-25

IMMUNE REGULATORY OLIGONUCLEOTIDE (IRO) COMPOUNDS TO MODULATE TOLL-LIKE RECEPTOR BASED IMMUNE RESPONSE

#54
20180021441
2018-01-25

Hyperbranched polymers and polyplexes and DNA or RNA delivery systems including the same

#55
20170312367
2017-11-02

Branched oligonucleotides

#56
20170211065
2017-07-27

Multimetric oligonucleotide compounds

#57
20170175122
2017-06-22

RNA-based compositions and adjuvants for prophylactic and therapeutic treatment

#58
20170121708
2017-05-04

Multifunctional RNA nanoparticles and methods of use

#59
20170107518
2017-04-20

RNA oligonucleotide and immune system enhancer comprising same

#60
20170002355
2017-01-05

cGAP-PNA MULTIVALENT PEPTIDE NUCLEIC ACID LIGAND DISPLAY

#61
20170002350
2017-01-05

TAILED MIRTRON EFFECTORS FOR RNAI-MEDIATED GENE SILENCING

#62
20160369275
2016-12-22

Modulation of transthyretin expression

#63
20160355808
2016-12-08

Oligonucleotide compounds for targeting huntingtin mRNA

#64
20160215287
2016-07-28

Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response

#65
20160160215
2016-06-09

Polynucleotides for multivalent RNA interference, compositions and methods of use thereof

#66
20160053267
2016-02-25

Multi-targets interfering RNA molecules and their applications

#67
20150315588
2015-11-05

Methods of delivering multiple targeting oligonucleotides to a cell using cleavable linkers

#68
20150315587
2015-11-05

Multimeric oligonucleotides compounds having cleavable linkers

#69
20150315586
2015-11-05

METHODS OF DELIVERING MULTIPLE TARGETING OLIGONUCLEOTIDES TO A CELL USING NON-NUCLEOTIDE BASED CLEAVABLE LINKERS

#70
20150315585
2015-11-05

Multimeric oligonucleotide compounds having non-nucleotide based cleavable linkers

#71
20150299695
2015-10-22

Multimeric oligonucleotides compounds

#72
20150203842
2015-07-23

Co-transcriptional assembly of modified RNA nanoparticles

#73
20140127255
2014-05-08

Chimeric immunomodulatory compounds and methods of using the same-IV

#74
20140004100
2014-01-02

Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response

#75
20120232126
2012-09-13

Multi-targets interfering RNA molecules and their applications

#76
20120231039
2012-09-13

Chimeric immunomodulatory compounds and methods of using the same-IV

#77
20120184598
2012-07-19

Polynucleotides for multivalent RNA interference, compositions and methods of use thereof

#78
20120128699
2012-05-24

Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response

#79
20120045430
2012-02-23

DENDRIMER-LIKE MODULAR DELIVERY VECTOR

#80
20120016007
2012-01-19

SMALL INTERFERENCE RNA COMPLEX WITH INCREASED INTRACELLULAR TRANSMISSION CAPACITY

#81
20110294868
2011-12-01

MODULATION OF TRANSTHYRETIN EXPRESSION

#82
20110159587
2011-06-30

Chimeric Molecules to Modulate Gene Expression

#83
20100330155
2010-12-30

METHODS AND COMPOSITIONS FOR IMPROVED THERAPEUTIC EFFECTS WITH siRNA

#84
20100323018
2010-12-23

Branched DNA/RNA monomers and uses thereof

#85
20100183634
2010-07-22

Multifunctional nucleic acid nano-structures

#86
20100166805
2010-07-01

Modulation of immunostimulatory properties by small oligonucleotide-based compounds

#87
20100152278
2010-06-17

RNA Interference Mediated Inhibition of Cyclic Nucleotide Type 4 Phosphodiesterase (PDE4B) Gene Expression Using Short Interfering Nucleic Acid (siNA)

#88
20100136614
2010-06-03

Dendrimer-like modular delivery vector

#89
20090317480
2009-12-24

Chimeric immunomodulatory compounds and methods of using the same-II

#90
20080311630
2008-12-18

DNA constructs for specific inhibition of gene expression by RNA interference

#91
20080311040
2008-12-18

METHODS AND COMPOSITIONS FOR IMPROVED THERAPEUTIC EFFECTS WITH siRNA

#92
20080305073
2008-12-11

Therapeutic Agents for the Treatment of Hmgb1-Related Pathologies

#93
20080293655
2008-11-27

Tandem siRNAS

#94
20080254443
2008-10-16

Norovirus detection, methods and compositions therefor

#95
20080188429
2008-08-07

Synthetic siRNA compounds and methods for the downregulation of gene expression

#96
20080181909
2008-07-31

Chimeric immunomodulatory compounds and methods of using the same

#97
20070161589
2007-07-12

Antisense modulation of CD40 expression

#98
20070049550
2007-03-01

Chimeric immunomodulatory compounds and methods of using the same—IV

#99
20070049543
2007-03-01

RNA interference mediated inhibition of 11 beta-hydroxysteroid dehydrogenase-1 (11 beta-HSD-1) gene expression using short interfering nucleic acid siNA

#100
20060003957
2006-01-05

RNA virus expression and replication, methods and uses therefor

#101
20050130918
2005-06-16

Modulation of immunostimulatory properties by small oligonucleotide-based compounds

#102
20050059016
2005-03-17

Structural motifs and oligomeric compounds and their use in gene modulation

#103
20050054836
2005-03-10

Chimeric molecules to modulate gene expression